Drug company gives ofatumumab update
Drug company gives ofatumumab update
Biotech firm Genmab has announced an update on development plans for ofatumumab in autoimmune indications focusing on relapsing multiple sclerosis following the transfer of the rights to ofatumumab from GlaxoSmithKline (GSK) to Novartis at the end of 2015...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1383 Views
-
Last post by frodo
-
- 0 Replies
- 1027 Views
-
Last post by frodo
-
- 0 Replies
- 2628 Views
-
Last post by NHE
-
- 0 Replies
- 1324 Views
-
Last post by frodo
-
- 0 Replies
- 1306 Views
-
Last post by frodo
-
- 0 Replies
- 1281 Views
-
Last post by frodo
-
- 0 Replies
- 1671 Views
-
Last post by NHE
-
- 0 Replies
- 526 Views
-
Last post by NHE
-
- 1 Replies
- 3167 Views
-
Last post by Tif